All Stories

  1. Association between partner treatment and repeat sexually transmitted infections positivity in pregnant women in East London, South Africa
  2. The persistent parasite: diagnosis and treatment of resistant Trichomonas vaginalis infection
  3. Bacterial Vaginosis Male Partner Treatment in the United States (Letter-to-the-Editor)
  4. Bacterial vaginosis: an overlooked STI?
  5. Response to STD-2025-175: Letter to the Editor
  6. Investigating Bacterial Vaginosis Pathogenesis Using Peptide Nucleic Acid-Fluorescence In Situ Hybridization With a Focus on the Roles of Gardnerella Species, Prevotella bivia, and Fannyhessea vaginae
  7. Nitazoxanide and tizoxanide demonstrate high levels of in vitro activity against metronidazole-susceptible and metronidazole-resistant Trichomonas vaginalis clinical isolates
  8. Trichomonas vaginalis Virus: Current Insights and Emerging Perspectives
  9. Bacterial vaginosis
  10. Key bacterial vaginosis-associated bacteria influence each other's growth in biofilms in rich media and media simulating vaginal tract secretions
  11. Trichomoniasis and Other Sexually Transmitted Parasitic Diseases in Women
  12. Adaptation of key bacterial vaginosis-associated bacteria to a medium simulating genital tract secretions: a transcriptomic analysis
  13. Bacterial Vaginosis — Time to Treat Male Partners
  14. Does a waiting room increase same-day treatment for sexually transmitted infections among pregnant women? A quality improvement study at South African primary healthcare facilities
  15. Gardnerella vaginalis, Fannyhessea vaginae, and Prevotella bivia Strongly Influence Each Other's Transcriptome in Triple-Species Biofilms
  16. Spontaneous resolution of Trichomonas vaginalis infection in men
  17. The Role of Prevotella Species in Female Genital Tract Infections
  18. Optimized bacterial absolute quantification method by qPCR using an exogenous bacterial culture as a normalization strategy in triple-species BV-like biofilms
  19. PerformingTrichomonas vaginalisculture in research studies in low-resource settings
  20. Microbial interactions amongGardnerella,PrevotellaandFannyhesseaprior to incident bacterial vaginosis: protocol for a prospective, observational study
  21. An Indirect Fluorescence Microscopy Method to Assess Vaginal Lactobacillus Concentrations
  22. Genital tract infections, the vaginal microbiome and gestational age at birth among pregnant women in South Africa: a cohort study protocol
  23. Efficacy of single-dose oral secnidazole for the treatment of trichomoniasis in women co-infected with trichomoniasis and bacterial vaginosis: a post hoc subgroup analysis of phase 3 clinical trial data
  24. Development of a Prevotella bivia PNA probe and a multiplex approach to detect three relevant species in bacterial vaginosis-associated biofilms
  25. A novel Gardnerella, Prevotella, and Lactobacillus standard that improves accuracy in quantifying bacterial burden in vaginal microbial communities
  26. State of the Art for Diagnosis of Bacterial Vaginosis
  27. Identification of Trichomonas vaginalis 5-Nitroimidazole Resistance Targets
  28. Impact of testosterone use on the vaginal microbiota of transgender men, including susceptibility to bacterial vaginosis: study protocol for a prospective, observational study
  29. Assessing recovery rates of distinct exogenous controls for gDNA extraction efficiency using phenol-chloroform or silica-column based extractions
  30. DNA extraction leads to bias in bacterial quantification by qPCR
  31. Sexually transmitted infections and female reproductive health
  32. Secnidazole: a treatment for trichomoniasis in adolescents and adults
  33. The Role of Antimicrobial Resistance in Refractory and Recurrent Bacterial Vaginosis and Current Recommendations for Treatment
  34. IgG4-Related Disease Masquerading as Culture-Negative Endocarditis
  35. The Role of Antimicrobial Resistance in Refractory and Recurrent Bacterial Vaginosis and Current Recommendations for Treatment
  36. Crystal Violet Staining Alone Is Not Adequate to Assess Synergism or Antagonism in Multi-Species Biofilms of Bacteria Associated With Bacterial Vaginosis
  37. Atopobium vaginae and Prevotella bivia Are Able to Incorporate and Influence Gene Expression in a Pre-Formed Gardnerella vaginalis Biofilm
  38. Asymptomatic Bacterial Vaginosis: to Treat or Not to Treat?
  39. Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection
  40. An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis
  41. Incubation period and risk factors support sexual transmission of bacterial vaginosis in women who have sex with women
  42. In Silico and Experimental Evaluation of Primer Sets for Species-Level Resolution of the Vaginal Microbiota Using 16S Ribosomal RNA Gene Sequencing
  43. Identification of Key Bacteria Involved in the Induction of Incident Bacterial Vaginosis: A Prospective Study
  44. Why Does Trichomonas vaginalis Continue to be a “Neglected” Sexually Transmitted Infection?
  45. O01.5 Origin and predictors of early repeat infections among hiv negative women withtrichomonas vaginalisreceiving a 2 g dose of metronidazole
  46. P2.33 Co-occurrence oftrichomonas vaginalisand bacterial vaginosis among women; prevalence and treatment outcomes
  47. Budgetary Impact of Compliance With STI Screening Guidelines in Persons Living With HIV
  48. Sexually Transmitted Infection Risk among Women Is Not Fully Explained by Partner Numbers
  49. Sexual orientation and sexual health services utilization among women in the United States
  50. Trichomonas vaginalis Treated With Boric Acid in a Metronidazole Allergic Female
  51. Trichomonas vaginalis Infections
  52. Sexual Orientation and Sexual and Reproductive Health among African American Sexual Minority Women in the U.S. South
  53. Trichomonas vaginalis Nucleic Acid Amplification Testing at an Urban HIV Clinic
  54. Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses
  55. Mucormycosis and Pharmacological Treatment Options
  56. Chlamydia trachomatis infection in African American women who exclusively have sex with women
  57. Screening for Sexually Transmitted Infections in Persons Living With Human Immunodeficiency Virus (HIV) Leads to Significant Financial Losses for a Healthcare System
  58. Accuracy of Self-Report of Sexual Activity among Adolescent Girls: Implications for Interpretation of Vaginal Flora Patterns
  59. Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections: Table 1.
  60. Women Who Have Sex With Women: A Unique Population for Studying the Pathogenesis of Bacterial Vaginosis
  61. Association between BVAB1 and high Nugent scores among women with bacterial vaginosis
  62. Sexual Partnership Characteristics of African American Women Who Have Sex With Women; Impact on Sexually Transmitted Infection Risk
  63. Lymphogranuloma Venereum Proctitis and Clostridium difficile Colitis in an HIV-Infected Patient
  64. Rickettsia parkeri: Eschar diagnosis
  65. Added Benefit of Nucleic Acid Amplification Testing for the Diagnosis of Trichomonas vaginalis Among Men and Women Attending a Sexually Transmitted Diseases Clinic
  66. Reply to Hickey and Forney
  67. Role of Gardnerella vaginalis in the Pathogenesis of Bacterial Vaginosis: A Conceptual Model
  68. Lack of evidence for sexual transmission of genitalCandidaspecies among women who have sex with women: a mixed methods study
  69. Suspected Heterosexual Transmission of Bacterial Vaginosis Without Seminal Fluid Exposure
  70. Families of choice and noncollegiate sororities and fraternities among lesbian and bisexual African-American women in a southern community: implications for sexual and reproductive health research
  71. Lower sexually transmissible infection prevalence among lifetime exclusive women who have sex with women compared with women who have sex with women and men
  72. Antibiotic Hypersensitivity Reactions and Approaches to Desensitization
  73. Characterization of the Vaginal Microbiota among Sexual Risk Behavior Groups of Women with Bacterial Vaginosis
  74. Diagnostic Rates Differ on the Basis of the Number of Read Days with the Use of the InPouch Culture System for Trichomonas vaginalis Screening
  75. Bacterial Vaginosis Among African American Women Who Have Sex With Women
  76. Sexual Behaviors, Perception of Sexually Transmitted Infection Risk, and Practice of Safe Sex Among Southern African American Women Who Have Sex With Women
  77. The clinical spectrum ofTrichomonas vaginalisinfection and challenges to management
  78. Trichomonas vaginalisinfection among women receiving gynaecological care at an Alabama HIV Clinic
  79. Gardnerella vaginalis: Still a Prime Suspect in the Pathogenesis of Bacterial Vaginosis
  80. Misperceptions regarding protective barrier method use for safer sex among African-American women who have sex with women
  81. Vaginal Infections
  82. Genetic Characterization of Trichomonas vaginalis Isolates by Use of Multilocus Sequence Typing
  83. A Fatal Case of Kaposi Sarcoma Due to Immune Reconstitution Inflammatory Syndrome
  84. Hansen's Disease (Leprosy): Current and Future Pharmacotherapy and Treatment of Disease-Related Immunologic Reactions
  85. Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: successful treatment with boric acid
  86. Sexually Transmitted Infections and Risk Behaviors Among African American Women Who Have Sex With Women: Does Sex With Men Make a Difference?
  87. Enterococcus faecium Vertebral Osteomyelitis and Its Association With Infective Endocarditis
  88. Vulvar Vaccinia Infection After Sexual Contact With a Smallpox Vaccinee
  89. Vomiting and Diarrhea in a 51-Year-Old Woman With Splenectomy
  90. Pneumococcal septic arthritis as the initial presentation of multiple myeloma